GI

We work with Pharmaceutical businesses (Prescription/ Generics) who have a GI portfolio on commercial and clinical talent acquisition.

Gastrointestinal Pharmaceuticals, which encompass medications and treatments for digestive system disorders, are essential for managing digestive disorders, preventing complications, and improving the quality of life for individuals with Gastrointestinal conditions.

We’ve seen more technological investment but also a rise in Biologics and Biosimilars to treat chronic diseases e.g. IBD, UC and Crohn’s as a result of more innovative medication to reduce side effects. This is creating opportunity for new market entrants as the market is more responsive to new and innovative treatments supporting patient’s quality of life.

If you’re looking to launch or grow in this market space let’s discuss the challenges.